Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Geriatrics (Basel, Switzerland)|April 27, 2026
Constipation in Older Adults: Pathophysiology, Clinical Impact, and Management StrategiesShima Mimura, Asahiro Morishita, Atsuo Kitaoka, et al.
Internal Medicine (Tokyo, Japan)|May 29, 2024
Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-upShima Mimura, Masafumi Ono, Koji Fujita, et al.
Cancers|March 29, 2023
Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion ChemotherapyKyoko Oura, Asahiro Morishita, Joji Tani, et al.
BMC Gastroenterology|April 2, 2024
Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patientsTomoko Tadokoro, Takako Nomura, Koji Fujita, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cellsYoshimi Yamana, Shintaro Fujihara, Hideki Kobara, et al.
Scientific Reports|May 11, 2024
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosisTomoko Tadokoro, Joji Tani, Takushi Manabe, et al.
International Journal of Molecular Sciences|February 15, 2022
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell LinesKei Takuma, Shintaro Fujihara, Koji Fujita, et al.
European Journal of Gastroenterology & Hepatology|September 14, 2020
L-carnitine reduces hospital admissions in patients with hepatic encephalopathyJoji Tani, Asahiro Morishita, Teppei Sakamoto, et al.
Journal of Gastroenterology|April 3, 2025
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinomaKyoko Oura, Asahiro Morishita, Rie Yano, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-upTomoko Tadokoro, Koji Fujita, Kei Takuma, et al.
Pageof 9